Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Addressing uncertainties in the management of urothelial and renal cell carcinomas

How to manage patients with durable response on systemic therapy? Optimal therapy duration and role de-escalation?

Date

14 Sep 2024

Session

Addressing uncertainties in the management of urothelial and renal cell carcinomas

Topics

Immunotherapy

Tumour Site

Urothelial Cancer

Presenters

Debbie Robbrecht

Authors

D. Robbrecht

Author affiliations

  • Medical Oncology Dept, Erasmus MC Cancer Institute, 3015 GD - Rotterdam/NL

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Circulating vs tissue-based biomarkers

Presenter: Bernadett Szabados

Session: Addressing uncertainties in the management of urothelial and renal cell carcinomas

Resources:

Slides

Webcast

Q&A and discussion

Session: Addressing uncertainties in the management of urothelial and renal cell carcinomas

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.